CN109293948B - 一种水凝胶及其制备方法和应用 - Google Patents
一种水凝胶及其制备方法和应用 Download PDFInfo
- Publication number
- CN109293948B CN109293948B CN201810911671.1A CN201810911671A CN109293948B CN 109293948 B CN109293948 B CN 109293948B CN 201810911671 A CN201810911671 A CN 201810911671A CN 109293948 B CN109293948 B CN 109293948B
- Authority
- CN
- China
- Prior art keywords
- quaternary ammonium
- hydrogel
- ammonium salt
- sodium alginate
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000017 hydrogel Substances 0.000 title claims abstract description 82
- 238000002360 preparation method Methods 0.000 title abstract description 39
- 239000000661 sodium alginate Substances 0.000 claims abstract description 83
- 235000010413 sodium alginate Nutrition 0.000 claims abstract description 83
- 229940005550 sodium alginate Drugs 0.000 claims abstract description 83
- 229920001661 Chitosan Polymers 0.000 claims abstract description 77
- -1 aldehyde sodium alginate Chemical class 0.000 claims abstract description 43
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims abstract description 41
- 229920002101 Chitin Polymers 0.000 claims abstract description 31
- 238000002156 mixing Methods 0.000 claims abstract description 19
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 48
- 238000006243 chemical reaction Methods 0.000 claims description 46
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 40
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 claims description 28
- 239000003607 modifier Substances 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 18
- 239000002262 Schiff base Substances 0.000 claims description 12
- 150000004753 Schiff bases Chemical class 0.000 claims description 12
- 125000003172 aldehyde group Chemical group 0.000 claims description 9
- 239000000178 monomer Substances 0.000 claims description 9
- 239000003960 organic solvent Substances 0.000 claims description 8
- 238000007254 oxidation reaction Methods 0.000 claims description 7
- PUVAFTRIIUSGLK-UHFFFAOYSA-M trimethyl(oxiran-2-ylmethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CC1CO1 PUVAFTRIIUSGLK-UHFFFAOYSA-M 0.000 claims description 7
- CSPHGSFZFWKVDL-UHFFFAOYSA-M (3-chloro-2-hydroxypropyl)-trimethylazanium;chloride Chemical compound [Cl-].C[N+](C)(C)CC(O)CCl CSPHGSFZFWKVDL-UHFFFAOYSA-M 0.000 claims description 6
- MPNXSZJPSVBLHP-UHFFFAOYSA-N 2-chloro-n-phenylpyridine-3-carboxamide Chemical compound ClC1=NC=CC=C1C(=O)NC1=CC=CC=C1 MPNXSZJPSVBLHP-UHFFFAOYSA-N 0.000 claims description 3
- 230000000850 deacetylating effect Effects 0.000 claims description 3
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 claims description 3
- RYDSVQYBXWIMMY-UHFFFAOYSA-M tributyl-[(4-ethenylphenyl)methyl]azanium;chloride Chemical compound [Cl-].CCCC[N+](CCCC)(CCCC)CC1=CC=C(C=C)C=C1 RYDSVQYBXWIMMY-UHFFFAOYSA-M 0.000 claims description 3
- CTKINSOISVBQLD-UHFFFAOYSA-N Glycidol Chemical compound OCC1CO1 CTKINSOISVBQLD-UHFFFAOYSA-N 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 18
- 230000003796 beauty Effects 0.000 abstract description 4
- 229920003023 plastic Polymers 0.000 abstract description 4
- 230000014759 maintenance of location Effects 0.000 abstract description 3
- 230000008439 repair process Effects 0.000 abstract description 3
- 230000000474 nursing effect Effects 0.000 abstract description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 84
- 239000000243 solution Substances 0.000 description 61
- 235000019441 ethanol Nutrition 0.000 description 32
- 239000000499 gel Substances 0.000 description 31
- 239000012153 distilled water Substances 0.000 description 25
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical group OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 21
- 238000003756 stirring Methods 0.000 description 20
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 14
- 239000000047 product Substances 0.000 description 13
- 239000000126 substance Substances 0.000 description 13
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
- 238000004132 cross linking Methods 0.000 description 12
- 238000000967 suction filtration Methods 0.000 description 12
- 238000001914 filtration Methods 0.000 description 10
- 239000002244 precipitate Substances 0.000 description 9
- 238000000502 dialysis Methods 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 238000001291 vacuum drying Methods 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 230000001476 alcoholic effect Effects 0.000 description 6
- 238000010382 chemical cross-linking Methods 0.000 description 6
- 239000003431 cross linking reagent Substances 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 238000005303 weighing Methods 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 5
- 241000191967 Staphylococcus aureus Species 0.000 description 5
- 230000003385 bacteriostatic effect Effects 0.000 description 5
- 239000012043 crude product Substances 0.000 description 5
- 230000007547 defect Effects 0.000 description 5
- 230000035876 healing Effects 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 231100000135 cytotoxicity Toxicity 0.000 description 4
- 230000003013 cytotoxicity Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 238000002791 soaking Methods 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 206010040880 Skin irritation Diseases 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 230000006196 deacetylation Effects 0.000 description 3
- 238000003381 deacetylation reaction Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000001376 precipitating effect Effects 0.000 description 3
- 238000005956 quaternization reaction Methods 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 206010059866 Drug resistance Diseases 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 150000004283 biguanides Chemical class 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000036573 scar formation Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
- C08J3/075—Macromolecular gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0052—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/008—Hydrogels or hydrocolloids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
- C08J2305/04—Alginic acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
- C08J2305/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Dispersion Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810911671.1A CN109293948B (zh) | 2018-08-10 | 2018-08-10 | 一种水凝胶及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810911671.1A CN109293948B (zh) | 2018-08-10 | 2018-08-10 | 一种水凝胶及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109293948A CN109293948A (zh) | 2019-02-01 |
CN109293948B true CN109293948B (zh) | 2021-01-26 |
Family
ID=65168173
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810911671.1A Active CN109293948B (zh) | 2018-08-10 | 2018-08-10 | 一种水凝胶及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109293948B (zh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20200338497A1 (en) * | 2019-04-29 | 2020-10-29 | Claude Steven McDaniel | Devices, facilities, methods and compositions for carbon dioxide capture, sequestration and utilization |
CN111269437A (zh) * | 2019-12-07 | 2020-06-12 | 中国海洋大学 | 一种兼具自愈性和黏附性的复合水凝胶的制备方法 |
CN111166931A (zh) * | 2020-01-21 | 2020-05-19 | 海南卓瑞生物医药有限公司 | 一种甲基丙烯酸丝胶/壳聚糖季铵盐水凝胶及其制备方法和应用 |
CN112844328B (zh) * | 2020-12-24 | 2023-12-12 | 武汉理工大学 | 一种海藻酸钠/壳聚糖季铵盐磁性吸附凝胶球及其制备方法和应用 |
CN113069589A (zh) * | 2021-02-22 | 2021-07-06 | 中国科学院大学温州研究院(温州生物材料与工程研究所) | 一种可生物降解的抗菌止血海绵 |
CN113855852B (zh) * | 2021-09-28 | 2022-06-28 | 蓝科医美科学技术(吉林)有限公司 | 一种含有人参提取物的修复敷料及其制备方法 |
CN113876788B (zh) * | 2021-10-29 | 2023-12-08 | 武汉大学 | 红景天苷水凝胶制剂及其制备方法和应用 |
CN114350034B (zh) * | 2021-12-01 | 2023-03-31 | 广东省科学院健康医学研究所 | 一种导电凝胶及其制备方法与应用 |
CN114230812A (zh) * | 2021-12-07 | 2022-03-25 | 广东省科学院健康医学研究所 | 一种功能性水凝胶及其制备方法和应用 |
CN114748677B (zh) * | 2022-04-20 | 2023-03-17 | 华中科技大学 | 一种抗粘连的水凝胶粘合剂及制备方法、应用 |
CN115429931B (zh) * | 2022-10-24 | 2023-08-15 | 山东爱基康健康科技有限公司 | 一种包含外泌体的壳聚糖水凝胶敷料及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101343334B (zh) * | 2008-07-16 | 2011-10-12 | 深圳大学 | O-2′-羟丙基三甲基氯化铵壳聚糖的制备方法 |
CN101463144B (zh) * | 2009-01-12 | 2010-12-29 | 武汉理工大学 | 羟丙基壳聚糖/氧化海藻酸钠自交联抗菌水凝胶材料的制备方法 |
CN105327388B (zh) * | 2015-12-07 | 2018-10-26 | 莫秀梅 | 一种医用粘合剂及其制备方法 |
-
2018
- 2018-08-10 CN CN201810911671.1A patent/CN109293948B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN109293948A (zh) | 2019-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109293948B (zh) | 一种水凝胶及其制备方法和应用 | |
Khattak et al. | Applications of cellulose and chitin/chitosan derivatives and composites as antibacterial materials: current state and perspectives | |
Morin-Crini et al. | Fundamentals and applications of chitosan | |
Kundu et al. | Cellulose hydrogels: Green and sustainable soft biomaterials | |
AU689692B2 (en) | Chitosan salts and process for the preparation thereof | |
CA2362233C (en) | Process for cross-linking hyaluronic acid to polymers | |
EP1749849B1 (en) | Materials having crosslinked polyrotaxane and process for producing these | |
EP0271551B1 (en) | Acid decrystallization of higly cristalline chitosan or partially deacylated chitin | |
CN109796606B (zh) | 一种基于多重动态化学键的自愈合水凝胶及其制备方法 | |
HU227731B1 (en) | Cross-linking process of carboxylated polysaccharides | |
EP1493754A1 (en) | Polysaccharide containing phosphorylcholine group and process for producing the same | |
CN114561046B (zh) | 一种胍基透明质酸型抗菌水凝胶及其制备方法和应用 | |
CN113444265A (zh) | 一种功能化二氧化钛抗菌水凝胶及其制备方法 | |
CN1331890C (zh) | 壳聚糖季铵盐的制备方法 | |
CN112618785B (zh) | 一种多孔抗菌水凝胶敷料及其制备方法 | |
Shao et al. | Dynamics in cellulose-based hydrogels with reversible cross-links | |
CN107987181A (zh) | 一种羟丙基可得然胶的制备方法及应用 | |
Brant et al. | Hydrogels from chitosan and a novel copolymer poly (N-vinyl-2-pyrrolidone-co-acrolein) | |
CN111154010B (zh) | 一种医用阳离子聚合物生物高分子材料及制备方法与应用 | |
CN114762736A (zh) | 一种离子液体改性壳聚糖水凝胶及其制备方法和应用 | |
Singha et al. | Chitosan-based bionanocomposites in medical textile | |
WO2022226633A1 (en) | Novel water-soluble chitosan compositions and method to prepare the same | |
JPH02107601A (ja) | 新規なキトサン化合物、その製造方法および保湿剤としての用途 | |
CN115350144A (zh) | 一种甲硝唑水凝胶及其制备方法 | |
JP5566038B2 (ja) | キチン−ポリアミノ酸複合組成物、その製造方法、および、キチン−ポリアミノ酸複合材料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: No. 1307, Guangzhou Avenue middle, Tianhe District, Guangzhou, Guangdong 510500 Patentee after: Institute of health medicine, Guangdong Academy of Sciences Address before: No. 1307, Guangzhou Avenue middle, Tianhe District, Guangzhou, Guangdong 510500 Patentee before: GUANGDONG INSTITUTE OF MEDICAL INSTRUMENTS |
|
CP01 | Change in the name or title of a patent holder | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231206 Address after: No.10, shiliugang Road, Haizhu District, Guangzhou City, Guangdong Province 510000 Patentee after: Institute of biological and medical engineering, Guangdong Academy of Sciences Address before: No. 1307, Guangzhou Avenue middle, Tianhe District, Guangzhou, Guangdong 510500 Patentee before: Institute of health medicine, Guangdong Academy of Sciences |
|
TR01 | Transfer of patent right |